News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,101 Results
Type
Article (41069)
Company Profile (302)
Press Release (670729)
Multimedia
Podcasts (65)
Webinars (14)
Section
Business (206090)
Career Advice (2045)
Deals (35676)
Drug Delivery (97)
Drug Development (81527)
Employer Resources (173)
FDA (16377)
Job Trends (15017)
News (348108)
Policy (32822)
Tag
Academia (2610)
Accelerated approval (10)
Adcomms (23)
Allergies (95)
Alliances (50282)
ALS (110)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (157)
Approvals (16375)
Artificial intelligence (325)
Autoimmune disease (30)
Automation (19)
Bankruptcy (364)
Best Places to Work (11720)
BIOSECURE Act (20)
Biosimilars (124)
Biotechnology (214)
Bladder cancer (95)
Brain cancer (34)
Breast cancer (372)
Cancer (2917)
Cardiovascular disease (215)
Career advice (1712)
Career pathing (31)
CAR-T (190)
CDC (30)
Cell therapy (510)
Cervical cancer (22)
Clinical research (67123)
Collaboration (1048)
Company closure (3)
Compensation (690)
Complete response letters (23)
COVID-19 (2653)
CRISPR (61)
C-suite (336)
Cystic fibrosis (114)
Data (3028)
Decentralized trials (2)
Denatured (24)
Depression (64)
Diabetes (348)
Diagnostics (6547)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (140)
Drug pricing (123)
Drug shortages (29)
Duchenne muscular dystrophy (131)
Earnings (87792)
Editorial (40)
Employer branding (21)
Employer resources (150)
Events (115073)
Executive appointments (865)
FDA (18064)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (950)
Gene editing (137)
Generative AI (24)
Gene therapy (382)
GLP-1 (794)
Government (4534)
Grass and pollen (4)
Guidances (182)
Healthcare (19027)
HIV (41)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (154)
Immuno-oncology (9)
Indications (39)
Infectious disease (2828)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (121)
Interviews (316)
IPO (16666)
IRA (46)
Job creations (3685)
Job search strategy (1451)
Kidney cancer (13)
Labor market (53)
Layoffs (501)
Leadership (20)
Legal (7972)
Liver cancer (80)
Longevity (11)
Lung cancer (404)
Lymphoma (210)
Machine learning (11)
Management (59)
Manufacturing (394)
MASH (92)
Medical device (13587)
Medtech (13592)
Mergers & acquisitions (19737)
Metabolic disorders (857)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (119)
Neuropsychiatric disorders (33)
Neuroscience (2148)
NextGen: Class of 2025 (6609)
Non-profit (4533)
Now hiring (48)
Obesity (431)
Opinion (223)
Ovarian cancer (101)
Pain (109)
Pancreatic cancer (123)
Parkinson's disease (186)
Partnered (22)
Patents (304)
Patient recruitment (169)
Peanut (50)
People (58296)
Pharmaceutical (70)
Pharmacy benefit managers (21)
Phase I (20951)
Phase II (29563)
Phase III (21988)
Pipeline (1652)
Policy (203)
Postmarket research (2567)
Preclinical (8945)
Press Release (66)
Prostate cancer (142)
Psychedelics (37)
Radiopharmaceuticals (255)
Rare diseases (465)
Real estate (5989)
Recruiting (66)
Regulatory (22810)
Reports (50)
Research institute (2379)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (86)
Series A (163)
Series B (111)
Service/supplier (13)
Sickle cell disease (62)
Special edition (19)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3672)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (39)
Vaccines (785)
Venture capital (56)
Weight loss (261)
Women's health (47)
Worklife (16)
Date
Today (75)
Last 7 days (345)
Last 30 days (1854)
Last 365 days (31583)
2025 (17135)
2024 (35630)
2023 (40516)
2022 (51615)
2021 (56174)
2020 (54473)
2019 (46961)
2018 (35335)
2017 (32470)
2016 (31878)
2015 (37933)
2014 (31620)
2013 (26680)
2012 (28932)
2011 (29565)
2010 (27632)
Location
Africa (730)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38726)
Australia (6327)
California (7547)
Canada (2375)
China (683)
Colorado (327)
Connecticut (326)
Delaware (192)
Europe (83737)
Florida (1129)
Georgia (254)
Hawaii (1)
Idaho (60)
Illinois (645)
India (28)
Indiana (363)
Iowa (17)
Japan (229)
Kansas (111)
Kentucky (29)
Louisiana (15)
Maine (64)
Maryland (1037)
Massachusetts (5633)
Michigan (247)
Minnesota (461)
Mississippi (3)
Missouri (97)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (67)
New Jersey (2088)
New Mexico (29)
New York (2114)
North Carolina (1089)
North Dakota (8)
Northern California (3310)
Ohio (241)
Oklahoma (16)
Oregon (35)
Pennsylvania (1622)
Puerto Rico (18)
Rhode Island (36)
South America (1111)
South Carolina (35)
South Dakota (1)
Southern California (2829)
Tennessee (127)
Texas (1140)
United States (27961)
Utah (223)
Virginia (194)
Washington D.C. (73)
Washington State (651)
West Virginia (4)
Wisconsin (66)
712,101 Results for "precision biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Tomorrow’s Precision Therapeutics Depend on Precision Diagnostics
Only with the adoption of digital imaging and AI-powered analysis will next-generation precision oncology therapies reach their full potential and ensure no eligible patient is overlooked.
July 14, 2025
·
3 min read
·
Robert Monroe
Press Releases
Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
June 25, 2025
·
9 min read
Press Releases
Octave Bioscience Expands Medical Leadership to Accelerate Precision Care in Neurodegenerative Disease
May 29, 2025
·
3 min read
Press Releases
Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025
May 8, 2025
·
1 min read
Press Releases
Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France
July 8, 2025
·
2 min read
Press Releases
Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
·
19 min read
Press Releases
Catheter Precision, Inc. Receives CE Mark for LockeT
May 27, 2025
·
3 min read
Press Releases
Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic
July 17, 2025
·
10 min read
Press Releases
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 9, 2025
·
3 min read
Press Releases
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
July 17, 2025
·
6 min read
1 of 71,211
Next
